期刊
JOURNAL OF THE AMERICAN HEART ASSOCIATION
卷 6, 期 10, 页码 -出版社
WILEY
DOI: 10.1161/JAHA.117.006885
关键词
hemodialysis; ketone body; metabolism; prognostic factor; beta-hydroxybutyrate
资金
- Kureha Corporation
- Select Foundation
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science, and Technology of Japan
- Gunma University Initiative for Advanced Research
- Grants-in-Aid for Scientific Research [17K09568, 16K19442] Funding Source: KAKEN
Background-Cardiovascular disease is the leading cause of morbidity and mortality in patients receiving hemodialysis. Systemic metabolic perturbation is one of the hallmark abnormalities in patients at high cardiovascular risk. We sought to determine the relationship between circulating ketone body and clinical outcomes in patients with prevalent hemodialysis. Methods and Results-We retrospectively assessed the relationship between serum beta-hydroxybutyrate (beta OHB), the most abundant ketone body in the circulation, and prognosis in 405 stable hemodialysis patients. During a mean follow-up of 3.2 +/- 0.9 years, there were 54 major adverse cardiovascular events (defined as cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and hospitalization attributed to heart failure) and 67 all-cause deaths. Major adverse cardiovascular events rates increased from 11.1 per 1000 person-years in the lowest beta OHB quintile (< 89 mu mol/L) to 80.1 per 1000 person-years in the highest quintile (>409 mu mol/L). After adjusting for demographic characteristics, coronary artery disease, and atrial fibrillation, the highest bOHB quintile was associated with increased risk of major adverse cardiovascular events compared with the lowest quintile (hazard ratio, 10.2; 95% confidence interval [3.35-44.0]; P<0.001). Increased quintiles of beta OHB were independently and incrementally associated with major adverse cardiovascular events over the model based on an established risk score (the second Analyzing Data, Recognizing Excellence and Optimizing Outcomes cohort score) and N-terminal pro-B-type natriuretic peptide (chi square 39.9 versus 21.7; P<0.001; c-statistics, 0.713). Sensitivity analyses also confirmed the robustness of association between beta OHB and all-cause death. Conclusions-Increased serum beta OHB levels were independently associated with cardiovascular events and all-cause death in patients receiving hemodialysis. These results highlight the need for future studies to understand the mechanisms underlying these observations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据